We are live on
!
Find out more
Schroder Investment Management Group Portfolio holdings
AUM
$122B
1-Year Est. Return
29.27%
This Fund
S&P 500
This Quarter
Est. Return
-2.16%
1 Year Est. Return
+29.27%
3 Year Est. Return
+98.87%
5 Year Est. Return
+131.84%
10 Year Est. Return
+513.68%
AUM
$99.1B
AUM Growth
-$5.32B
(-5.1%)
Cap. Flow
-$740M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
27.72%
Holding
1,277
New
83
Increased
445
Reduced
587
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$927M |
| 2 |
Broadcom
AVGO
|
+$406M |
| 3 |
Blackrock
BLK
|
+$362M |
| 4 |
Carrier Global
CARR
|
+$224M |
| 5 |
Lam Research
LRCX
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$325M |
| 2 |
Tesla
TSLA
|
+$304M |
| 3 |
GE Vernova
GEV
|
+$283M |
| 4 |
NVIDIA
NVDA
|
+$280M |
| 5 |
Zebra Technologies
ZBRA
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.33% |
| 2 | Financials | 13.48% |
| 3 | Communication Services | 12.67% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Healthcare | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Cheesecake Factory
CAKE
$5.63B
| $1.03M | ﹤0.01% |
+20,685
| New | +$1.06M |
|
952
Incyte
INCY
$24.5B
| $1.02M | ﹤0.01% |
16,753
-178,640
| -91% | -$12.5M |
|
953
First Citizens BancShares
FCNCA
$25.4B
| $1M | ﹤0.01% |
545
+83
| +18% | +$169K |
|
954
Applied Industrial Technologies
AIT
$13B
| $992K | ﹤0.01% |
4,398
+355
| +9% | +$87.5K |
|
955
Factset
FDS
$10.1B
| $992K | ﹤0.01% |
2,210
-351
| -14% | -$160K |
|
956
Western Digital
WDC
$151B
| $988K | ﹤0.01% |
24,431
-19,051
| -44% | -$904K |
|
957
Align Technology
ALGN
$12.3B
| $979K | ﹤0.01% |
6,149
-134
| -2% | -$26.3K |
|
958
Textron
TXT
$15.2B
| $976K | ﹤0.01% |
13,367
-1,737
| -12% | -$130K |
|
959
Rhythm Pharmaceuticals
RYTM
$7.77B
| $965K | ﹤0.01% |
+17,618
| New | +$977K |
|
960
Insulet
PODD
$10B
| $964K | ﹤0.01% |
3,727
-48
| -1% | -$13K |
|
961
Tango Therapeutics
TNGX
$4.44B
| $963K | ﹤0.01% |
655,158
| – | – |
|
962
Celldex Therapeutics
CLDX
$3.48B
| $959K | ﹤0.01% |
48,099
| – | – |
|
|
HOLX
963
DELISTED
Hologic
HOLX
| $953K | ﹤0.01% |
15,548
-260
| -2% | -$17.2K |
|
964
Ulta Beauty
ULTA
$23.3B
| $952K | ﹤0.01% |
2,597
-785
| -23% | -$299K |
|
965
DraftKings
DKNG
$12.6B
| $944K | ﹤0.01% |
26,753
| – | – |
|
966
Labcorp
LH
$26.1B
| $940K | ﹤0.01% |
4,039
-1,515
| -27% | -$368K |
|
967
Moderna
MRNA
$24.2B
| $938K | ﹤0.01% |
30,136
-1,968
| -6% | -$69.8K |
|
968
BHP
BHP
$229B
| $936K | ﹤0.01% |
19,140
-4,610
| -19% | -$230K |
|
969
WD-40
WDFC
$3.13B
| $925K | ﹤0.01% |
3,826
-597
| -13% | -$141K |
|
970
Mineralys Therapeutics
MLYS
$2.41B
| $922K | ﹤0.01% |
+62,893
| New | +$723K |
|
971
Badger Meter
BMI
$3.93B
| $915K | ﹤0.01% |
4,809
-1,136
| -19% | -$237K |
|
|
BPMC
972
DELISTED
Blueprint Medicines
BPMC
| $908K | ﹤0.01% |
10,231
-28,203
| -73% | -$2.75M |
|
973
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
| $903K | ﹤0.01% |
11,436
-11,247
| -50% | -$882K |
|
974
Essential Utilities
WTRG
$11.4B
| $902K | ﹤0.01% |
22,946
-86,672
| -79% | -$3.18M |
|
975
Procore
PCOR
$8.93B
| $889K | ﹤0.01% |
13,301
-2,430
| -15% | -$183K |
|
Similar funds
VAM
Schroder Investment Management Group's Q1 2025 Portfolio in Review
As of Q1 2025, Schroder Investment Management Group held 1,277 positions worth $99.1B, down 5.1% from $104B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Schroder Investment Management Group's Q1 2025 filing shows 83 new, 445 increased, 587 reduced and 91 closed positions. Its largest new stake was Arista Networks: 9,143,531 shares worth $708M. The largest sale was Merck, an estimated $325M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Financials and Communication Services.
- Schroder Investment Management Group's largest Q1 2025 buy was Arista Networks: 9,143,531 shares worth $708M.
- Schroder Investment Management Group added most to Broadcom in Q1 2025, an estimated $406M increase.
- Schroder Investment Management Group's biggest Q1 2025 reduction was Merck, cutting an estimated $325M.
- Schroder Investment Management Group fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $62M.
- Schroder Investment Management Group's ten largest holdings make up 28% of its $99.1B portfolio in Q1 2025.
- Schroder Investment Management Group opened 83 new positions and closed 91 in Q1 2025.
- Schroder Investment Management Group's portfolio value fell 5.1% quarter-over-quarter to $99.1B.
Based on Schroder Investment Management Group's 13F filing for Q1 2025, filed 13 May 2025.